RESMED INC
ResMed Inc. is a global leader in digital health and cloud-connected medical devices. The company specializes in solutions for sleep and respiratory care, focusing on improving patient outcomes, creating efficiencies for customers, and reducing healthcare system costs. ResMed was founded in 1989 in Australia and went public in the United States in 1995. The company operates in two segments: Sleep and Respiratory Care, and Software as a Service (SaaS). The Sleep and Respiratory Care segment deals with sleep-disordered breathing, including obstructive sleep apnea (OSA), and respiratory care for chronic obstructive pulmonary disease (COPD), neuromuscular diseases, and other chronic respiratory conditions. The company offers a range of devices, diagnostic products, mask systems, headgear, dental devices, and cloud-based software and informatics solutions. The SaaS segment focuses on software platforms for durable or home medical equipment (DME/HME) providers and other long-term care providers, enabling them to streamline workflow, manage documentation, and implement new reimbursement requirements. ResMed's business strategy includes continuing product development and innovation, expanding SaaS solutions in out-of-hospital care settings, expanding geographic presence, increasing public and clinical awareness, and exploring new clinical applications. The company's website is www.resmed.com, and its stock is traded on the New York Stock Exchange under the ticker symbol "RMD" and on the Australian Securities Exchange under the symbol "RMD."